Backed by market attractiveness analysis, total addressable market sizing, company benchmarking matrices, interactive Excel dashboards, wider supply chain intelligence, emerging startup coverage, and detailed product-level insights, The Business Research Company’s 2026 market reports are designed to offer research that is more actionable and strategically valuable than ever.
#Stents Market Revenue Outlook: What CAGR Lies Ahead Through 2030?#_x000D_
The stents market has experienced significant growth in recent years. Its value is projected to increase from $11.81 billion in 2025 to $12.49 billion in 2026, exhibiting a compound annual growth rate (CAGR) of 5.8%. This historical expansion can be attributed to several factors, including a limited selection of stent materials, the prevalence of bare-metal stents, a rising incidence of coronary artery disease, the development of hospital infrastructure, and the increasing utilization of angioplasty procedures._x000D_
_x000D_
The stents market size is anticipated to experience robust expansion over the next few years, projected to reach $15.62 billion in 2030 at a compound annual growth rate (CAGR) of 5.7%. This growth during the forecast period is driven by the development of drug-eluting and bioabsorbable stents, the expansion of neurovascular and peripheral interventions, increased investment in stent research and development, a growing aging population with cardiovascular conditions, and the integration of smart and AI-assisted stent deployment systems. Prominent trends for this period include the rising adoption of drug-eluting and bioabsorbable stents, the increasing utilization of peripheral and neurovascular stents, a strong focus on minimally invasive procedures and endovascular surgeries, the escalating demand for customized stent designs and materials, and enhanced regulatory compliance along with post-market surveillance._x000D_
_x000D_
#Get A Free Sample Report With In-Depth Market Insights:#_x000D_
_x000D_
#Stents Market Industry Drivers: What’s Behind The Revenue Growth?#_x000D_
The increasing prevalence of cardiovascular conditions is projected to drive the expansion of the stents market in the future. These disorders encompass health issues impacting the heart or blood vessels, impeding the heart’s proper functioning. The rise in cardiovascular disorders stems from insufficient physical activity, which can lead to obesity, elevated blood pressure, and compromised cardiovascular health by diminishing heart and circulatory efficiency. Stent insertion aids in managing cardiovascular disorders by re-establishing and sustaining blood flow in constricted or obstructed arteries, thus mitigating the likelihood of heart attacks and associated complications. For example, as reported by the British Heart Foundation, a UK-based cardiovascular research charity, in January 2025, approximately 7.6 million individuals in the UK were affected by heart and circulatory diseases, comprising around 4 million men and 3.6 million women. These conditions account for nearly 27% of all deaths nationwide, leading to more than 170,000 annual fatalities, or roughly 480 deaths daily. Consequently, the rising incidence of cardiovascular disorders is fueling the expansion of the stent market._x000D_
_x000D_
#Stents Market Segment Analysis Spotlighting Growth Areas#_x000D_
The stents market covered in this report is segmented – _x000D_
_x000D_
1) By Product: Coronary Stents, Peripheral Stents, Stent-Related Implants, Biliary Stents, Carotid Stents, Neurovascular Stents_x000D_
2) By Material: Metallic Biomaterial, Polymer Biomaterial_x000D_
3) By End User: Hospitals And Clinics, Ambulatory Surgical Centers, Other End User_x000D_
_x000D_
Subsegments:_x000D_
1) By Coronary Stents: Drug-Eluting Stents, Bare-Metal Stents, Bioabsorbable Stents_x000D_
2) By Peripheral Stents: Iliac Artery Stents, Femoral-Popliteal Artery Stents, Renal Artery Stents, Tibial Artery Stents_x000D_
3) By Stent-Related Implants: Stent Grafts, Endovascular Stent Grafts, Covered Stents_x000D_
4) By Biliary Stents: Plastic Biliary Stents, Metallic Biliary Stents, Self-Expanding Biliary Stents_x000D_
5) By Carotid Stents: Balloon-Expandable Carotid Stents, Self-Expanding Carotid Stents_x000D_
6) By Neurovascular Stents: Flow Diverter Stents, Self-Expanding Neurovascular Stents, Balloon-Expandable Neurovascular Stents_x000D_
_x000D_
#Stents Market Growth Trends: What’s Shaping The Future Outlook?_x000D_
Leading companies within the stent market are concentrating on creating innovative technologies, such as drug eluting stents, to enhance efficacy, reduce restenosis rates, and improve patient outcomes. These drug eluting stents consist of small mesh tubes, deployed within arteries, which gradually release medication aimed at preventing the vessel from re-narrowing subsequent to treatment. For instance, in April 2023, Terumo Europe N.V., a Belgium-based medical device company, unveiled the Ultimaster Nagomi sirolimus-eluting coronary stent system for complex percutaneous coronary intervention (PCI) patients, after receiving CE mark certification. This system is engineered to enhance deliverability in challenging anatomies, facilitate shorter dual-antiplatelet therapy (DAPT) regimens for high bleeding-risk patients, and preserve optimal radial strength. Furthermore, it incorporates advanced polymer technology to guarantee consistent drug release and promote improved endothelial healing._x000D_
_x000D_
#Stents Market Competitive Landscape: Which Companies Lead The Industry?#_x000D_
Major companies operating in the stents market are Abbott Laboratories, Medtronic plc, Boston Scientific Corporation, Terumo Corporation, B Braun Melsungen AG, Cook Medical, Biotronik SE and Co KG, MicroPort Scientific Corporation, Meril Life Sciences, Biosensors International Group Ltd, Elixir Medical Corporation, Veryan Medical Limited, Vascular Concepts Ltd, Novatech SA, Merit Medical Systems Inc, Teleflex Incorporated, Micro Tech Europe, Balton Sp z oo, Endologix Inc, Cardinal Health Interventional, Nipro Medical Corporation, Optimed Medizinische Instrumente GmbH _x000D_
_x000D_
#View The Full Stents Market Report:#_x000D_
_x000D_
#Stents Market Regional Outlook: Where Is Opportunity Concentrated?#_x000D_
North America was the largest region in the stents market in 2025. Asia-Pacific is expected to be the fastest-growing region in the forecast period. The regions covered in the stents market report are Asia-Pacific, South East Asia, Western Europe, Eastern Europe, North America, South America, Middle East, Africa._x000D_
_x000D_
#Reach Out To Our Team:#_x000D_
_x000D_
The Business Research Company: https://www.thebusinessresearchcompany.com/_x000D_
Americas: +1 310-496-7795_x000D_
Asia: +44 7882 955267 & +91 8897263534_x000D_
Europe: +44 7882 955267_x000D_
Email us at: marketing@tbrc.info_x000D_
_x000D_
#Follow us on:#_x000D_
_x000D_
LinkedIn: https://in.linkedin.com/company/the-business-research-company_x000D_
YouTube: https://www.youtube.com/channel/UC24_fI0rV8cR5DxlCpgmyFQ_x000D_
Global Market Model: https://www.thebusinessresearchcompany.com/global-market-model
Wasay has over a decade of experience in market research, data modelling, and analytics, with prior experience at GlobalData and Decision Tree Consulting Services. At The Business Research Company , he leads research operations across syndicated studies, customized consulting engagements, and the Global Market Model platform. His professional experience includes supporting organizations such as Boston Consulting Group, KPMG, and Ernst & Young. Wasay holds a degree in Electronics and Communications Engineering, postgraduate management qualifications from International Management Institute Belgium and Indian School of Business and Entrepreneurship, and completed the Integrated Program in Business Analytics from Indian Institute of Management Indore.